Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biodesix, Inc. - Common Stock (NQ:BDSX)

24.93 -0.77 (-3.00%)
Delayed Quote Updated: 10:18 AM EDT, Oct 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biodesix, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
Biodesix Analysts Lower Their Forecasts After Downbeat Q1 Results ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Top movers in Tuesday's after hours session ↗
The US market regular session of Tuesday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
News headline image
Biodesix Announces First Quarter 2025 Results and Highlights
From Biodesix, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Biodesix to Report First Quarter 2025 Financial Results on May 13, 2025
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For May 13, 2025 ↗
 
Via Benzinga
News headline image
Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types
Aggregate analysis of eight clinical trials of patients with advanced non-small cell lung cancer (aNSCLC) was supported by Biodesix, using Bio-Rad Droplet Digital™ PCR technology 
From Biodesix, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Top movers in Tuesday's after hours session ↗
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
News headline image
US Futures Tumble As Traders Await Trump's Congress Address: 'Volatility Is Certainly Being Fed By Trump 2.0 Moves,' Says Expert ↗
U.S. stock futures declined on Tuesday following the worst trading day of 2025 on Monday. Futures fell in premarket trading except Nasdaq 100. 
Via Benzinga
Topics Economy Government
News headline image
Get insights into the top gainers and losers of Monday's after-hours session. ↗
Discover the top movers in Monday's after-hours session and stay informed about the post-market dynamics. 
Via Chartmill
News headline image
Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For March 3, 2025 ↗
 
Via Benzinga
News headline image
Biodesix to Present at TD Cowen 45th Annual Health Care Conference
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
From Biodesix, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited)
Grew full-year revenue to an estimated $71.3 million, an increase of 45% 
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study
Analysis of 447 patients receiving the Nodify CDT blood-based lung nodule test published in CHEST Pulmonary Journal reaffirms test performance 
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix Announces Third Quarter 2024 Results and Highlights
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix to Participate in Three Investor Conferences in November
From Biodesix, Inc.
Via GlobeNewswire
News headline image
Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024
From Biodesix, Inc.
Via Business Wire
News headline image
Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study
From Biodesix, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Phoenix Motor Shares Are Trading Higher By 150%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Biodesix to Present at Two Investor Conferences in September
From Biodesix, Inc.
Via Business Wire
News headline image
BDSX Stock Earnings: Biodesix Beats EPS, Beats Revenue for Q2 2024 ↗
BDSX stock results show that Biodesix beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.